OR WAIT 15 SECS
Angie Drakulich was editorial director of Pharmaceutical Technology.
On Sept. 12, 2012, PhRMA is cohosting a brand new national awards program in Washington, DC, to honor individuals and organizations that have contributed significantly to the fight against Alzheimer's Disease.
On Sept. 12, 2012, the Pharmaceutical Research and Manufacturers of America (PhRMA) is cohosting a brand new national awards program at the Newseum in Washington, DC, to honor individuals and organizations who have contributed significantly to the advancement of patient care and medical innovation in the US. The new annual awards, called the Research and Hope Awards, are replacing PhRMA’s Discoverer’s Award, and this year, will focus on the fight against Alzheimer’s Disease. The Alzheimer's Foundation of America, the National Alliance for Caregiving, and the National Association for Home Care & Hospice are cohosting the 2012 event. Pharmaceutical Technology is a media partner to the awards, which will be given in the following categories, according to PhRMA:
“This award ceremony celebrates the evolution of research and progress made in the battle against such a complex and devastating disease. Yet, despite the enormous challenges biopharmaceutical scientists continue to face fighting Alzheimer’s, the achievements we will be recognizing give us hope,” said John J. Castellani, president and CEO of PhRMA. “This is also an opportunity to better recognize those individuals who have devoted their lives to helping patients suffering from such a debilitating disease.”
The science award winners are being selected by a special committee of the PhRMA Foundation. The advocacy awards are being selected by a committee made up of PhRMA and cohost representatives. Interviews with the winners will appear in the December 2012 issue of Pharmaceutical Technology. For more information, visit the PhRMA Awards website.
Related Content:PharmTech News